美股市场个股详情

Kiniksa Pharmaceuticals International (KNSA)

添加自选
  • 55.270
  • +1.490+2.77%
收盘价 05/01 16:00 (美东)
  • 55.270
  • 0.0000.00%
盘后 20:01 (美东)
42.52亿总市值60.74市盈率TTM

Kiniksa Pharmaceuticals International (KNSA) 利润表

季报+年报
显示同比 yoy
隐藏空行 yoy
(Q1)2026/03/31
(FY)2025/12/31
(Q4)2025/12/31
(Q3)2025/09/30
(Q2)2025/06/30
(Q1)2025/03/31
(FY)2024/12/31
(Q4)2024/12/31
(Q3)2024/09/30
(Q2)2024/06/30
营业总收入
55.51%2.14亿
60.09%6.78亿
64.95%2.02亿
61.17%1.81亿
44.34%1.57亿
72.54%1.38亿
56.60%4.23亿
46.93%1.23亿
67.37%1.12亿
51.99%1.09亿
营业收入
55.51%2.14亿
60.09%6.78亿
64.95%2.02亿
61.17%1.81亿
44.34%1.57亿
72.54%1.38亿
56.60%4.23亿
46.93%1.23亿
67.37%1.12亿
51.99%1.09亿
主营业务成本
56.30%9,637.3万
62.36%3.07亿
37.66%9,097.5万
69.10%8,356.4万
67.76%7,102.1万
96.46%6,165.8万
110.41%1.89亿
149.16%6,608.5万
87.19%4,941.6万
95.23%4,233.6万
毛利
54.86%1.18亿
58.26%3.7亿
96.90%1.11亿
54.93%9,729.1万
29.39%8,577.6万
57.05%7,612.7万
29.77%2.34亿
-0.74%5,645.1万
54.50%6,279.8万
33.15%6,629.5万
营业费用
41.00%8,862.6万
4.82%2.93亿
20.64%9,138.4万
1.12%7,327万
-1.20%6,561.6万
-3.32%6,285.5万
36.06%2.8亿
33.38%7,575万
40.49%7,245.6万
25.44%6,641.2万
销售和管理费用
40.48%6,115.1万
16.82%1.96亿
40.06%5,677.5万
5.83%4,910.4万
10.54%4,686.3万
12.53%4,353万
29.81%1.68亿
10.33%4,053.5万
34.61%4,639.9万
45.31%4,239.5万
研发费用
42.17%2,747.5万
-13.23%9,685.3万
-1.72%3,460.9万
-7.26%2,416.6万
-21.92%1,875.3万
-26.62%1,932.5万
46.69%1.12亿
75.62%3,521.5万
52.33%2,605.7万
1.05%2,401.7万
其他营业费用
----
----
----
----
----
----
127.00%1.28亿
----
----
----
营业利润
120.52%2,926.7万
269.28%7,722.1万
202.43%1,976.8万
348.72%2,402.1万
17,330.77%2,016万
180.23%1,327.2万
-81.04%-4,561.6万
-23,925.93%-1,929.9万
11.61%-965.8万
96.29%-11.7万
净非营业利息收入(费用)
其他净收入(费用)
48.89%341.4万
23.07%1,164.7万
50.91%350.1万
27.64%313.6万
12.23%271.7万
1.19%229.3万
10.77%946.4万
-2.07%232万
1.19%245.7万
26.42%242.1万
其他非经营收入(费用)
48.89%341.4万
23.07%1,164.7万
50.91%350.1万
27.64%313.6万
12.23%271.7万
1.19%229.3万
10.77%946.4万
-2.07%232万
1.19%245.7万
26.42%242.1万
税前利润
109.96%3,268.1万
345.82%8,886.8万
237.05%2,326.9万
477.13%2,715.7万
892.93%2,287.7万
209.03%1,556.5万
-117.10%-3,615.2万
-793.02%-1,697.9万
15.27%-720.1万
285.96%230.4万
所得税
43.60%1,008.9万
324.13%2,986.3万
212.10%907万
58.81%872.2万
-18.79%504.5万
104.96%702.6万
122.91%704.1万
64.49%-809.1万
2.54%549.2万
138.32%621.2万
除税后利润
164.57%2,259.2万
236.61%5,900.5万
259.75%1,419.9万
245.24%1,843.5万
556.29%1,783.2万
148.23%853.9万
-406.68%-4,319.3万
-135.22%-888.8万
8.39%-1,269.3万
-126.10%-390.8万
持续经营利润
164.57%2,259.2万
236.61%5,900.5万
259.75%1,419.9万
245.24%1,843.5万
556.29%1,783.2万
148.23%853.9万
-406.68%-4,319.3万
-135.22%-888.8万
8.39%-1,269.3万
-126.10%-390.8万
归属于少数股东的净利润
归属于母公司的净利润
164.57%2,259.2万
236.61%5,900.5万
259.75%1,419.9万
245.24%1,843.5万
556.29%1,783.2万
148.23%853.9万
-406.68%-4,319.3万
-135.22%-888.8万
8.39%-1,269.3万
-126.10%-390.8万
优先股派息
其他优先股派息
归属于普通股股东的净利润
164.57%2,259.2万
236.61%5,900.5万
259.75%1,419.9万
245.24%1,843.5万
556.29%1,783.2万
148.23%853.9万
-406.68%-4,319.3万
-135.22%-888.8万
8.39%-1,269.3万
-126.10%-390.8万
基本每股收益
150.00%0.3
233.33%0.8
258.33%0.19
238.89%0.25
500.00%0.24
148.00%0.12
-400.00%-0.6
-133.33%-0.12
10.00%-0.18
-128.57%-0.06
稀释每股收益
145.45%0.27
225.00%0.75
241.67%0.17
227.78%0.23
483.33%0.23
144.00%0.11
-400.00%-0.6
-134.29%-0.12
10.00%-0.18
-128.57%-0.06
每股派息
货币单位
美元
美元
美元
美元
美元
美元
美元
美元
美元
美元
会计准则
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
审计意见
--
无保留意见
--
--
--
--
无保留意见
--
--
--
(Q1)2026/03/31(FY)2025/12/31(Q4)2025/12/31(Q3)2025/09/30(Q2)2025/06/30(Q1)2025/03/31(FY)2024/12/31(Q4)2024/12/31(Q3)2024/09/30(Q2)2024/06/30
营业总收入 55.51%2.14亿60.09%6.78亿64.95%2.02亿61.17%1.81亿44.34%1.57亿72.54%1.38亿56.60%4.23亿46.93%1.23亿67.37%1.12亿51.99%1.09亿
营业收入 55.51%2.14亿60.09%6.78亿64.95%2.02亿61.17%1.81亿44.34%1.57亿72.54%1.38亿56.60%4.23亿46.93%1.23亿67.37%1.12亿51.99%1.09亿
主营业务成本 56.30%9,637.3万62.36%3.07亿37.66%9,097.5万69.10%8,356.4万67.76%7,102.1万96.46%6,165.8万110.41%1.89亿149.16%6,608.5万87.19%4,941.6万95.23%4,233.6万
毛利 54.86%1.18亿58.26%3.7亿96.90%1.11亿54.93%9,729.1万29.39%8,577.6万57.05%7,612.7万29.77%2.34亿-0.74%5,645.1万54.50%6,279.8万33.15%6,629.5万
营业费用 41.00%8,862.6万4.82%2.93亿20.64%9,138.4万1.12%7,327万-1.20%6,561.6万-3.32%6,285.5万36.06%2.8亿33.38%7,575万40.49%7,245.6万25.44%6,641.2万
销售和管理费用 40.48%6,115.1万16.82%1.96亿40.06%5,677.5万5.83%4,910.4万10.54%4,686.3万12.53%4,353万29.81%1.68亿10.33%4,053.5万34.61%4,639.9万45.31%4,239.5万
研发费用 42.17%2,747.5万-13.23%9,685.3万-1.72%3,460.9万-7.26%2,416.6万-21.92%1,875.3万-26.62%1,932.5万46.69%1.12亿75.62%3,521.5万52.33%2,605.7万1.05%2,401.7万
其他营业费用 ------------------------127.00%1.28亿------------
营业利润 120.52%2,926.7万269.28%7,722.1万202.43%1,976.8万348.72%2,402.1万17,330.77%2,016万180.23%1,327.2万-81.04%-4,561.6万-23,925.93%-1,929.9万11.61%-965.8万96.29%-11.7万
净非营业利息收入(费用)
其他净收入(费用) 48.89%341.4万23.07%1,164.7万50.91%350.1万27.64%313.6万12.23%271.7万1.19%229.3万10.77%946.4万-2.07%232万1.19%245.7万26.42%242.1万
其他非经营收入(费用) 48.89%341.4万23.07%1,164.7万50.91%350.1万27.64%313.6万12.23%271.7万1.19%229.3万10.77%946.4万-2.07%232万1.19%245.7万26.42%242.1万
税前利润 109.96%3,268.1万345.82%8,886.8万237.05%2,326.9万477.13%2,715.7万892.93%2,287.7万209.03%1,556.5万-117.10%-3,615.2万-793.02%-1,697.9万15.27%-720.1万285.96%230.4万
所得税 43.60%1,008.9万324.13%2,986.3万212.10%907万58.81%872.2万-18.79%504.5万104.96%702.6万122.91%704.1万64.49%-809.1万2.54%549.2万138.32%621.2万
除税后利润 164.57%2,259.2万236.61%5,900.5万259.75%1,419.9万245.24%1,843.5万556.29%1,783.2万148.23%853.9万-406.68%-4,319.3万-135.22%-888.8万8.39%-1,269.3万-126.10%-390.8万
持续经营利润 164.57%2,259.2万236.61%5,900.5万259.75%1,419.9万245.24%1,843.5万556.29%1,783.2万148.23%853.9万-406.68%-4,319.3万-135.22%-888.8万8.39%-1,269.3万-126.10%-390.8万
归属于少数股东的净利润
归属于母公司的净利润 164.57%2,259.2万236.61%5,900.5万259.75%1,419.9万245.24%1,843.5万556.29%1,783.2万148.23%853.9万-406.68%-4,319.3万-135.22%-888.8万8.39%-1,269.3万-126.10%-390.8万
优先股派息
其他优先股派息
归属于普通股股东的净利润 164.57%2,259.2万236.61%5,900.5万259.75%1,419.9万245.24%1,843.5万556.29%1,783.2万148.23%853.9万-406.68%-4,319.3万-135.22%-888.8万8.39%-1,269.3万-126.10%-390.8万
基本每股收益 150.00%0.3233.33%0.8258.33%0.19238.89%0.25500.00%0.24148.00%0.12-400.00%-0.6-133.33%-0.1210.00%-0.18-128.57%-0.06
稀释每股收益 145.45%0.27225.00%0.75241.67%0.17227.78%0.23483.33%0.23144.00%0.11-400.00%-0.6-134.29%-0.1210.00%-0.18-128.57%-0.06
每股派息
货币单位 美元美元美元美元美元美元美元美元美元美元
会计准则 US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
审计意见 --无保留意见--------无保留意见------
热门市场机会
热门中概股
查看更多
中东战火燃至股市!投资者该如何应对?
5月1日,持续两个多月的美以伊军事冲突迎来法律节点,可能会使特朗普政府在未来几天压力增大。届时若国会未能续批授权,对伊军事行动将依法终止。此外,美伊停战又有变数!自伊朗方面获悉,伊朗已向巴基斯坦提交了其最新谈判方案文本,由巴方作为与美国进行谈判的中间人。以色列媒体报道说,美国“可 展开